Cargando…

Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy

Hepatocellular carcinoma (HCC), one of the most common and lethal tumors worldwide, is usually not diagnosed until the disease is advanced, which results in ineffective intervention and unfavorable prognosis. Small molecule targeted drugs of HCC, such as sorafenib, provided only about 2.8 months of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shao-Li, Wang, Yu-Ming, Wang, Quan-Yue, Feng, Guang-Gui, Wu, Fu-Qing, Yang, Liu-Ming, Zhang, Xi-He, Xin, Hong-Wu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296838/ https://www.ncbi.nlm.nih.gov/pubmed/34306031 http://dx.doi.org/10.3389/fgene.2021.691391

Ejemplares similares

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma
por: Zhang, Shirong, et al.
Publicado: (2022)

Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma
por: Zheng, Susu, et al.
Publicado: (2021)

Clinical Significance and Potential Mechanisms of ATP Binding Cassette Subfamily C Genes in Hepatocellular Carcinoma
por: Zhou, Xin, et al.
Publicado: (2022)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Liang, et al.
Publicado: (2021)

Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Tang, Pingfei, et al.
Publicado: (2021)

Mechanism Analysis of LINC00665 and Its Peptides CIP2A-BP in Hepatocellular Carcinoma
por: Li, Yi-Ran, et al.
Publicado: (2022)

A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma
por: Liang, Xin-Yi, et al.
Publicado: (2022)

The Clinical Significance and Potential Molecular Mechanism of PTTG1 in Esophageal Squamous Cell Carcinoma
por: Chen, Shang-Wei, et al.
Publicado: (2021)

Circular RNAs in hepatocellular carcinoma: biogenesis, function, and pathology
por: Rao, Guocheng, et al.
Publicado: (2023)

Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma
por: Chen, Min, et al.
Publicado: (2022)

Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
por: Zhao, Ming, et al.
Publicado: (2023)

Comprehensive multiomics analysis of cuproptosis-related gene characteristics in hepatocellular carcinoma
por: Fu, Jie, et al.
Publicado: (2022)

Identification of Aging-Related Genes Associated With Clinical and Prognostic Features of Hepatocellular Carcinoma
por: Chen, Xingte, et al.
Publicado: (2021)

Circular RNAs Sparkle in the Diagnosis and Theranostics of Hepatocellular Carcinoma
por: Wang, Menglan, et al.
Publicado: (2021)

Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma
por: Wu, Qiong, et al.
Publicado: (2022)

Development and Validation of Genome Instability-Associated lncRNAs to Predict Prognosis and Immunotherapy of Patients With Hepatocellular Carcinoma
por: Yan, Yifeng, et al.
Publicado: (2022)

Risk model of hepatocellular carcinoma based on cuproptosis-related genes
por: Liu, Zhiqiang, et al.
Publicado: (2022)

Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma
por: Wu, Han, et al.
Publicado: (2021)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular Carcinoma
por: Wang, Wen-Jie, et al.
Publicado: (2020)

Identification of a nucleotide metabolism-related signature to predict prognosis and guide patient care in hepatocellular carcinoma
por: Li, Yu, et al.
Publicado: (2023)

Systematic Analysis Identifies a Specific RNA-Binding Protein-Related Gene Model for Prognostication and Risk-Adjustment in HBV-Related Hepatocellular Carcinoma
por: Li, Maoshi, et al.
Publicado: (2021)

Identification of Core Genes Related to Progression and Prognosis of Hepatocellular Carcinoma and Small-Molecule Drug Predication
por: Jiang, Nan, et al.
Publicado: (2021)

Comprehensive Analysis of the Prognosis and Correlations With Immune Infiltration of S100 Protein Family Members in Hepatocellular Carcinoma
por: Zheng, Susu, et al.
Publicado: (2021)

N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
por: Regmi, Parbatraj, et al.
Publicado: (2022)

The Prognostic Significance and Potential Mechanism of Ferroptosis-Related Genes in Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma
por: Sun, Liang, et al.
Publicado: (2022)

Advances in single-cell sequencing technology in the field of hepatocellular carcinoma
por: Qin, Rongyi, et al.
Publicado: (2022)

Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma
por: Liang, Tao-tao, et al.
Publicado: (2020)

Translated Long Non-Coding Ribonucleic Acid ZFAS1 Promotes Cancer Cell Migration by Elevating Reactive Oxygen Species Production in Hepatocellular Carcinoma
por: Guo, Zhi-Wei, et al.
Publicado: (2019)

Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning
por: Wang, Jiaying, et al.
Publicado: (2022)

A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening
por: Chen, Min, et al.
Publicado: (2022)

Prognostic value of LECT2 and relevance to immune infiltration in hepatocellular carcinoma
por: Qin, Jiangfeng, et al.
Publicado: (2022)

Identification and Validation of Ferroptosis-Related Biomarkers in Septic Cardiomyopathy via Bioinformatics Analysis
por: Gong, Cheng-Wu, et al.
Publicado: (2022)

Integrated Analysis Reveals Critical Ferroptosis Regulators and FTL Contribute to Cancer Progression in Hepatocellular Carcinoma
por: Ke, Shaoying, et al.
Publicado: (2022)

Single-cell transcriptome sequencing reveals potential novel combination of biomarkers for antibody-based cancer therapeutics in hepatocellular carcinoma
por: Tang, Hong, et al.
Publicado: (2022)

Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oeagpf6ftnh0gh9r7spgah598s